drugset / Trial / NCT03365999

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.

NCT03365999 ↗

Phase 2 Completed 92 enrolled Autonomous University of Nuevo León
RandomizedParallel-groupSingle-blindPrevention

Summary

This study compares two oral medications (tranexamic acid and aminocaproic acid) as hemostatic agent administered in patients undergoing total knee replacement.

Timeline

Start
2017-10-15
Primary completion
2019-07-01
Completion
2019-07-01

Outcome

Mixed primary results

paper Primary outcome measures included transfusions, estimated blood loss, and the drop in the hemoglobin (Hgb) level. PMID 28976426 ↗

paper Although the patients who received TXA averaged less estimated blood loss than the patients who received EACA (t185 = 2.18, p = 0.031; PMID 28976426 ↗

paper no transfusions were required in either group. PMID 28976426 ↗

paper We observed no statistically significant or clinically relevant between-group differences in the change in Hgb PMID 28976426 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 1 g Oral
Comparator Tranexamic Acid Small molecule 1.3 g Oral